- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Neoprobe lands J&J as partner
Gamma probe developer Neoprobe has signed an agreement with Johnson & Johnson’s Ethicon Endo-Surgery division for sales and marketing of Neoprobe 1500, a portable radioisotope detector recently released by Neoprobe. Ethicon Endo-Surgery of
Gamma probe developer Neoprobe has signed an agreement with Johnson & Johnsons Ethicon Endo-Surgery division for sales and marketing of Neoprobe 1500, a portable radioisotope detector recently released by Neoprobe. Ethicon Endo-Surgery of Cincinnati, OH, will have rights to promote Neoprobe 1500 and its reusable probes for one year in the U.S., and the two companies are in discussions over extending the deal to cover Europe, Japan, and Australia. Neoprobe of Dublin, OH, previously had an agreement with U.S. Surgical, but that deal broke down last year.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
